Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells. (Q40790023)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Epstein–Barr virus

0 references

membrane protein

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

T Noguchi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

K Ikeda

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

K Yamamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

I Yoshida

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Ashiba

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Tsuchiyama

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

K Shinagawa

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

T Yoshino

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Harada

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

114

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

84-92

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11472349%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

The 30-bp deletion variant of Epstein-Barr virus-encoded latent membrane protein-1 prevails in acute infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

No direct role for Epstein-Barr virus in oral carcinogenesis: a study at the DNA, RNA and protein levels

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Epstein-Barr virus: LMP1 masquerades as an active receptor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Treatment outcome and prognostic factors for primary nasal lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Prevalence of Epstein-Barr viral sequences and EBV LMP1 oncogene deletions in Burkitt's lymphoma from Pakistan: epidemiological correlations.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02887.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40790023&oldid=1507238897"